FIELD: medicine, pulmonology. SUBSTANCE: method involves the medicinal therapy with additional intravenous administration of sodium hypochlorite to patients at concentration 220-330 mg/l at dose 0.1-0.2 ml/kg weight, every day. EFFECT: enhanced effectiveness of treatment. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR STIMULATION OF MONOCYTIC PHAGOCYTOSIS IN PATIENTS WITH CHRONIC NONSPECIFIC PULMONARY DISEASES | 1994 |
|
RU2085196C1 |
METHOD FOR TREATING CHRONIC NONSPECIFIC LUNG DISEASES | 1991 |
|
RU2043765C1 |
METHOD FOR PREVENTING EXACERBATIONS OF CHRONIC INFLAMMATORY PULMONARY DISEASES IN CHILDREN | 2003 |
|
RU2252784C1 |
METHOD FOR TREATMENT OF PULMONARY DISEASES | 1993 |
|
RU2077881C1 |
METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA AND/OR CYSTIC FIBROSIS ACCOMPANYING INFLUENZA IN CHILDREN | 2013 |
|
RU2522276C1 |
METHOD FOR IMMUNOCORRECTION OF CHRONIC OBSTRUCTIVE BRONCHITIS | 2007 |
|
RU2347588C1 |
METHOD FOR PREDICTION OF PROBABILITY OF FAVOURABLE OR LETHAL OUTCOME IN PATIENTS SUFFERING FROM INFECTIOUS-INFLAMMATORY URINARY DISEASES | 2012 |
|
RU2517110C2 |
METHOD FOR TREATING BRONCHOPULMONARY DISEASES | 1992 |
|
RU2039559C1 |
PEPTIDE HAVING BRONCHOPROTECTIVE ACTION, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHOD FOR USE THEREOF | 2021 |
|
RU2767532C1 |
METHOD FOR TREATING CHRONIC BRONCHOPULMONARY PROCESS AT INBORN DEFECTS OF PULMONARY DEVELOPMENT IN CHILDREN | 2003 |
|
RU2253484C1 |
Authors
Dates
1997-01-20—Published
1994-02-24—Filed